David Watson notifies proposed sale of AGX stock (AGX) on 06/16/2026

Rhea-AI Filing Summary

David Watson submitted a notice under Rule 144 relating to proposed sales of Common Stock of AGX. The filing lists a planned equity grant/exercise of 1,880 shares on 06/16/2026 and reports shares sold in the past three months of 9,993 shares on 06/15/2026 and 19,310 shares on 04/17/2026.

Key Figures

Option exercise shares: 1,880 shares Sale on 06/15/2026: 9,993 shares Sale on 04/17/2026: 19,310 shares +2 more

5 metrics

Option exercise shares 1,880 shares Option exercise dated 06/16/2026

Sale on 06/15/2026 9,993 shares Reported sale dated 06/15/2026

Sale on 04/17/2026 19,310 shares Reported sale dated 04/17/2026

Proceeds reported (06/15/2026 row) $6,507,641.46 Dollar amount adjacent to 06/15/2026 sale row as shown

Proceeds reported (04/17/2026 row) $11,626,744.10 Dollar amount adjacent to 04/17/2026 sale row as shown

Key Terms

Form 144, Rule 144, Option exercise

3 terms

Form 144 regulatory

"144: Securities To Be Sold | Common Stock | 06/16/2026"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 144 regulatory

"144: Filer Information"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Option exercise financial

"06/16/2026 | OPTION EXERCISE"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	1880	1303686	14019247	06/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/16/2026	EQUITY GRANT	Issuer			1880	06/16/2026	OPTION EXERCISE

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Watson 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common Stock	06/15/2026	9993	6507641.46
David Watson 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common Stock	04/17/2026	19310	11626744.1

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AGX's Form 144 filed by David Watson disclose?

It discloses proposed sales of Common Stock and an equity exercise. It lists an option exercise of 1,880 shares on 06/16/2026 and past sales of 9,993 and 19,310 shares on the cited dates.

How many shares did David Watson report selling in the past three months for AGX?

The filing reports two past sales: 9,993 shares on 06/15/2026 and 19,310 shares on 04/17/2026. Dollar amounts are shown alongside those sale rows in the excerpt.

Does the Form 144 show an option exercise for AGX?

Yes. The excerpt lists an OPTION EXERCISE for 1,880 shares with an associated date of 06/16/2026 under the Securities To Be Sold section.

Are proceeds or recipients of the reported sales specified in the excerpt?

The excerpt shows numeric dollar figures next to the past sales rows but does not explicitly name who received proceeds; cash‐flow treatment is not described in the excerpt.

Where were the securities to be sold listed as held or brokered?

The filing references Raymond James & Associates at an address and lists the security as Common Stock traded on NYSE with a 06/16/2026 date in the excerpt.